logo
Sign in

PODD Stock Price, Chart, Stats & News

Insulet Corporation
Save
10.14B
Market cap
34.27x
Current P/E
23.87x
Forward P/E

PODD chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
71.63%
Operating margin
17.50%
Pretax margin
12.54%
Net margin
9.12%
Effective tax rate
27.19%
ROA
7.75%
ROE
17.36%
D/E
0.69x
Interest coverage ratio
7.40x

PODD valuation

P/E
34.27x
P/S
5.41x
P/B
9.67x
P/CF
25.74x
P/FCF
38.81x
P/OCF
25.74x
PEG
207.52x
EV multiple
29.44x

About

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.

Similar securities

Based on sector and market capitalization

Report issue